insights_auto
Why is INO down 21,95%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
0,60 $
arrow_downward
-21,95%(-0,17) 1D
2,06 $
arrow_upward
+241,97% (+1,46)bedtimeAfter hours
Closed: 30 қаз., 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
0,86 $
High
0,86 $
Low
0,60 $
Mkt. cap
62,43 млн
Avg. vol.
3,86 млн
Volume
80,50 млн
52-wk high
2,72 $
52-wk low
0,57 $
EPS
-1,17 $
Beta
1,61
Shares outstanding
103,40 млн
No. of employees
112
Open
0,86 $
High
0,86 $
Low
0,60 $
Mkt. cap
62,43 млн
Avg. vol.
3,86 млн
Volume
80,50 млн
52-wk high
2,72 $
52-wk low
0,57 $
EPS
-1,17 $
Beta
1,61
Shares outstanding
103,40 млн
No. of employees
112
News stories
From web sources and news partners
BigGo Finance
·
13 сағат бұрын
FDA Grants Accelerated Approval to Inovio's DNA Immunotherapy Voceryq; Precigen Shares Plunge 27% After Hours
GuruFocus
·
14 сағат бұрын
Inovio Pharmaceuticals (INO) Soars 280% After FDA Approves Vocer
The Business Journals
·
14 сағат бұрын
After 43 years, Inovio gets its first FDA-approved drug in 'milestone' decision
Yahoo Finance
·
14 сағат бұрын
PGEN Stock Craters 27% After-Hours After Rival Inovio's Rare Disease Drug Receives FDA Approval
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc